Erdheim-Chester disease presenting as periodontal disease: Experience of treatment with cladribine, interferon-a, local radiotherapy and anakinra

Acta Oncol. 2016;55(2):248-50. doi: 10.3109/0284186X.2015.1023463. Epub 2015 Apr 23.

Authors

Lena Blomstrand¹, Andreas Thor², Hans Hagberg³

Affiliations

¹ a Department of Surgical Sciences , Oral and Maxillofacial Surgery, Uppsala University , Uppsala , Sweden.
² b Department of Surgical Sciences , Oral and Maxillofacial Surgery, Uppsala University , Uppsala , Sweden.
³ c Department of Radiology , Oncology and Radiation Science, Oncology, Uppsala University , Uppsala , Sweden.

PMID: 25902723
DOI: 10.3109/0284186X.2015.1023463

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Cladribine / therapeutic use*
Erdheim-Chester Disease / diagnosis
Erdheim-Chester Disease / drug therapy*
Erdheim-Chester Disease / radiotherapy*
Humans
Interferon-alpha / therapeutic use*
Interleukin 1 Receptor Antagonist Protein / therapeutic use
Male
Periodontal Diseases / diagnosis
Periodontal Diseases / drug therapy*
Periodontal Diseases / radiotherapy*

Substances

Interferon-alpha
Interleukin 1 Receptor Antagonist Protein
Cladribine